Skip to main content

Advertisement

SpringerLink
Log in

Upregulation of fibroblast growth factor receptor 2 and 3 in the late stages of fetal lung development in the nitrofen rat model

  • Original Article
  • Published:
Pediatric Surgery International Aims and scope Submit manuscript

Abstract

Purpose

Nitrofen model of congenital diaphragmatic hernia (CDH) has been widely used to investigate the pathogenesis of pulmonary hypoplasia (PH). Fibroblast growth factor (FGF) signaling pathway plays a fundamental role in fetal lung development. FGF7 and FGF10, which are critical for lung morphogenesis, have been reported to be downregulated in nitrofen-induced PH. FGF signaling is mediated by a family of four single transmembrane receptors, FGFR1–4. FGFR2 and FGFR3 have been shown to be expressed predominantly in the late stages of developing lungs. In addition, the upregulation of FGFR2 gene expression has been associated with severe defects in lung development and resulted in arrested alveologenesis similar to PH seen in the nitrofen model. Furthermore, FGFR3−/−FGFR4−/− double mutants showed thinner mesenchyme and larger air spaces. We designed this study to test the hypothesis that FGFR gene expression is upregulated in the late stages of lung development in the nitrofen CDH model.

Methods

Pregnant rats were exposed to either olive oil or nitrofen on day 9 of gestation (D9). Cesarean section was performed and fetuses were harvested on D18 and D21. Fetal lungs were divided into three groups: control, nitrofen without CDH [CDH(−)], and nitrofen with CDH [CDH(+)] (n = 24 at each time-point). Pulmonary gene expression levels of FGFR1–4 were analyzed by real-time RT-PCR. Immunohistochemistry was also performed to evaluate protein expression/distribution at each time-point.

Results

The relative messenger RNA expression levels of pulmonary FGFR2 and FGFR3 on D21 were significantly increased in CDH(−) (6.38 ± 1.93 and 7.84 ± 2.86, respectively) and CDH(+) (7.09 ± 2.50 and 7.25 ± 3.43, respectively) compared to controls (P < 0.05 and P < 0.01, respectively), whereas no significant alteration was observed on D18. There were no differences in FGFR1 and FGFR4 expression at both time-points. Increased immunoreactivity of FGFR2 and FGFR3, mainly in the distal epithelium and mesenchyme, was observed in the nitrofen-induced hypoplastic lungs on D21 compared to controls.

Conclusion

Upregulation of FGFR2 and FGFR3 pulmonary gene expression in the late stages of fetal lung development may disrupt FGFR-mediated alveologenesis resulting in PH in the CDH model.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

  1. Bohn D (2002) Congenital diaphragmatic hernia. Am J Respir Crit Care Med 166(7):911–915

    Article  PubMed  Google Scholar 

  2. Stege G, Fenton A, Jaffray B (2003) Nihilism in the 1990s: the true mortality of congenital diaphragmatic hernia. Pediatrics 112(3 Pt 1):532–535

    Article  PubMed  Google Scholar 

  3. Gosche JR, Islam S, Boulanger SC (2005) Congenital diaphragmatic hernia: searching for answers. Am J Surg 190(2):324–332

    Article  PubMed  Google Scholar 

  4. Sabharwal AJ, Davis CF, Howatson AG (2000) Post-mortem findings in fetal and neonatal congenital diaphragmatic hernia. Eur J Pediatr Surg 10(2):96–99

    Article  PubMed  CAS  Google Scholar 

  5. Noble BR, Babiuk RP, Clugston RD et al (2007) Mechanisms of action of the congenital diaphragmatic hernia-inducing teratogen nitrofen. Am J Physiol Lung Cell Mol Physiol 293(4):1079–1087

    Article  Google Scholar 

  6. Montedonico S, Nakazawa N, Puri P (2008) Congenital diaphragmatic hernia and retinoids: searching for an etiology. Pediatr Surg Int 24(7):755–761

    Article  PubMed  Google Scholar 

  7. Lebeche D, Malpel S, Cardoso WV (1999) Fibroblast growth factor interactions in the developing lung. Mech Dev 86(1–2):125–136

    Article  PubMed  CAS  Google Scholar 

  8. Warburton D, Schwarz M, Tefft D et al (2000) The molecular basis of lung morphogenesis. Mech Dev 92(1):55–81

    Article  PubMed  CAS  Google Scholar 

  9. Dionne CA, Crumley G, Bellot F et al (1990) Cloning and expression of two distinct high-affinity receptors cross-reacting with acidic and basic fibroblast growth factors. EMBO J 9(9):2685–2692

    PubMed  CAS  Google Scholar 

  10. Keegan K, Johnson DE, Williams LT et al (1991) Isolation of an additional member of the fibroblast growth factor receptor family, FGFR-3. Proc Natl Acad Sci USA 88(4):1095–1099

    Article  PubMed  CAS  Google Scholar 

  11. Partanen J, Makela TP, Eerola E et al (1991) FGFR-4, a novel acidic fibroblast growth factor receptor with a distinct expression pattern. EMBO J 10(6):1347–1354

    PubMed  CAS  Google Scholar 

  12. Thisse B, Thisse C (2005) Functions and regulations of fibroblast growth factor signaling during embryonic development. Dev Biol 287(2):390–402

    Article  PubMed  CAS  Google Scholar 

  13. Lin X, Buff EM, Perrimon N et al (1999) Heparan sulfate proteoglycans are essential for FGF receptor signaling during Drosophila embryonic development. Development 126(17):3715–3723

    PubMed  CAS  Google Scholar 

  14. Metzger RJ, Krasnow MA (1999) Genetic control of branching morphogenesis. Science 284(5420):1635–1639

    Article  PubMed  CAS  Google Scholar 

  15. Teramoto H, Yoneda A, Puri P (2003) Gene expression of fibroblast growth factors 10 and 7 is downregulated in the lung of nitrofen-induced diaphragmatic hernia in rats. J Pediatr Surg 38(7):1021–1024

    Article  PubMed  Google Scholar 

  16. Powell PP, Wang CC, Horinouchi H et al (1998) Differential expression of fibroblast growth factor receptors 1 to 4 and ligand genes in late fetal and early postnatal rat lung. Am J Respir Cell Mol Biol 19(4):563–572

    PubMed  CAS  Google Scholar 

  17. De Langhe SP, Carraro G, Warburton D et al (2006) Levels of mesenchymal FGFR2 signaling modulate smooth muscle progenitor cell commitment in the lung. Dev Biol 299(1):52–62

    Article  PubMed  Google Scholar 

  18. Weinstein M, Xu X, Ohyama K et al (1998) FGFR-3 and FGFR-4 function cooperatively to direct alveogenesis in the murine lung. Development 125(18):3615–3623

    PubMed  CAS  Google Scholar 

  19. Cardoso WV (2001) Molecular regulation of lung development. Annu Rev Physiol 63:471–494

    Article  PubMed  CAS  Google Scholar 

  20. Sekine K, Ohuchi H, Fujiwara M et al (1999) Fgf10 is essential for limb and lung formation. Nat Genet 21(1):138–141

    Article  PubMed  CAS  Google Scholar 

  21. Ornitz DM, Xu J, Colvin JS et al (1996) Receptor specificity of the fibroblast growth factor family. J Biol Chem 271(25):15292–15297

    Article  PubMed  CAS  Google Scholar 

  22. Han RN, Liu J, Tanswell AK et al (1992) Expression of basic fibroblast growth factor and receptor: immunolocalization studies in developing rat fetal lung. Pediatr Res 31(5):435–440

    Article  PubMed  CAS  Google Scholar 

  23. Moura RS, Coutinho-Borges JP, Pacheco AP et al (2011) FGF signaling pathway in the developing chick lung: expression and inhibition studies. PLoS One 6(3):17660

    Article  Google Scholar 

  24. Peters KG, Werner S, Chen G et al (1992) Two FGF receptor genes are differentially expressed in epithelial and mesenchymal tissues during limb formation and organogenesis in the mouse. Development 114(1):233–243

    PubMed  CAS  Google Scholar 

  25. Cool SM, Sayer RE, van Heumen WR et al (2002) Temporal and spatial expression of fibroblast growth factor receptor 4 isoforms in murine tissues. Histochem J 34(6–7):291–297

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. National Children’s Research Centre, Our Lady’s Children’s Hospital, Crumlin, Dublin 12, Ireland

    Florian Friedmacher, Takashi Doi, Jan-Hendrik Gosemann, Naho Fujiwara, Balazs Kutasy & Prem Puri

  2. School of Medicine and Medical Science and Conway Institute of Biomolecular and Biomedical Research, University College Dublin, Dublin, Ireland

    Prem Puri

Authors
  1. Florian Friedmacher
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Takashi Doi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jan-Hendrik Gosemann
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Naho Fujiwara
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Balazs Kutasy
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Prem Puri
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Prem Puri.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Friedmacher, F., Doi, T., Gosemann, JH. et al. Upregulation of fibroblast growth factor receptor 2 and 3 in the late stages of fetal lung development in the nitrofen rat model. Pediatr Surg Int 28, 195–199 (2012). https://doi.org/10.1007/s00383-011-2985-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00383-011-2985-2

Keywords

Search

Navigation